Detalhe da pesquisa
1.
Multifunctional NK Cell-Engaging Antibodies Targeting EGFR and NKp30 Elicit Efficient Tumor Cell Killing and Proinflammatory Cytokine Release.
J Immunol
; 209(9): 1724-1735, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36104113
2.
Affinity Maturation of B7-H6 Translates into Enhanced NK Cell-Mediated Tumor Cell Lysis and Improved Proinflammatory Cytokine Release of Bispecific Immunoligands via NKp30 Engagement.
J Immunol
; 206(1): 225-236, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33268483
3.
Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancer.
Clin Exp Immunol
; 209(1): 22-32, 2022 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325068
4.
Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers.
MAbs
; 16(1): 2315640, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38372053
5.
Affinity Maturation of the Natural Ligand (B7-H6) for Natural Cytotoxicity Receptor NKp30 by Yeast Surface Display.
Methods Mol Biol
; 2681: 231-248, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37405651
6.
NKp46-specific single domain antibodies enable facile engineering of various potent NK cell engager formats.
Protein Sci
; 32(3): e4593, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36775946
7.
Generation and engineering of potent single domain antibody-based bispecific IL-18 mimetics resistant to IL-18BP decoy receptor inhibition.
MAbs
; 15(1): 2236265, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37469014
8.
Identification of New Antibodies Targeting Malignant Plasma Cells for Immunotherapy by Next-Generation Sequencing-Assisted Phage Display.
Front Immunol
; 13: 908093, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35784366
9.
Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody.
Front Immunol
; 13: 957874, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36119088